Sol-Gel Technologies
Nes Ziyyona
About Sol-Gel Technologies
Sol-Gel designs and delivers innovative dermatological drugs ranging from completely non-leachable to highly-controlled-release of unique formulations and compounds.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $33.1M
- Funding stage: M&A
- Last round: Post-IPO Equity (Mar 2026)
- Ticker: nasdaq:SLGL
- Website: sol-gel.com
- Phone: 972 8 931 3433
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/sol-gel-technologies-101288 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.